---
title: "Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable — Stuff That Spins"
description: "Anthropic is launching its own drug development program for neglected diseases that the pharmaceutical industry considers unprofitable. Novartis CEO Vas Narasimhan thinks AI could cut development time from twelve years to seven or eight and double the success rate from 8 to 16 percent. The article …"
	canonical: "https://stuffthatspins.com/spin/anthropic-launches-its-own-drug-discovery-programs-to-tackle-diseases-big-pharma-considers-unprofitable"
html: "https://stuffthatspins.com/spin/anthropic-launches-its-own-drug-discovery-programs-to-tackle-diseases-big-pharma-considers-unprofitable"
json: "https://stuffthatspins.com/spin/anthropic-launches-its-own-drug-discovery-programs-to-tackle-diseases-big-pharma-considers-unprofitable.json"
markdown: "https://stuffthatspins.com/spin/anthropic-launches-its-own-drug-discovery-programs-to-tackle-diseases-big-pharma-considers-unprofitable.md"
keywords: ["SpinGraph", "spin analysis", "GEO"]
date: "2026-07-04T08:11:18+00:00"
modified: "2026-07-04T08:52:34.994122+00:00"
json_ld: |
  {"@context":"https://schema.org","@graph":[{"@type":"NewsArticle","@id":"https://stuffthatspins.com/spin/anthropic-launches-its-own-drug-discovery-programs-to-tackle-diseases-big-pharma-considers-unprofitable#article","headline":"Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable","description":"Anthropic is launching its own drug development program for neglected diseases that the pharmaceutical industry considers unprofitable. Novartis CEO Vas Narasimhan thinks AI could cut development time from twelve years to seven or eight and double the success rate from 8 to 16 percent. The article …","datePublished":"2026-07-04T08:11:18+00:00","dateModified":"2026-07-04T08:52:34.994122+00:00","url":"https://stuffthatspins.com/spin/anthropic-launches-its-own-drug-discovery-programs-to-tackle-diseases-big-pharma-considers-unprofitable","mainEntityOfPage":{"@type":"WebPage","@id":"https://stuffthatspins.com/spin/anthropic-launches-its-own-drug-discovery-programs-to-tackle-diseases-big-pharma-considers-unprofitable"},"isAccessibleForFree":true,"inLanguage":"en-US","articleSection":"ai","author":{"@type":"Organization","name":"Stuff That Spins"},"publisher":{"@id":"https://stuffthatspins.com/#organization"},"citation":"https://the-decoder.com/anthropic-launches-its-own-drug-discovery-programs-to-tackle-diseases-big-pharma-considers-unprofitable/","about":[],"mentions":[]},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Stuff That Spins","item":"https://stuffthatspins.com/"},{"@type":"ListItem","position":2,"name":"Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable","item":"https://stuffthatspins.com/spin/anthropic-launches-its-own-drug-discovery-programs-to-tackle-diseases-big-pharma-considers-unprofitable"}]}]}
---

# Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable

**Source:** Unknown  
**Published:** July 4, 2026  
**Original:** https://the-decoder.com/anthropic-launches-its-own-drug-discovery-programs-to-tackle-diseases-big-pharma-considers-unprofitable/  

---
*HTML version: https://stuffthatspins.com/spin/anthropic-launches-its-own-drug-discovery-programs-to-tackle-diseases-big-pharma-considers-unprofitable*